Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsIslet cell transplantation for the treatment of type 1 diabetes: recent advances and future challengesRasGAP-derived fragment N increases the resistance of beta cells towards apoptosis in NOD mice and delays the progression from mild to overt diabetes.Noninvasive assessment of tissue-engineered graft viability by oxygen-17 magnetic resonance spectroscopy.Slow and steady is the key to beta-cell replication.Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sitesCaspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.β-Cells with relative low HIMP1 overexpression levels in a transgenic mouse line enhance basal insulin production and hypoxia/hypoglycemia tolerance.Regulation of the CCL2 gene in pancreatic β-cells by IL-1β and glucocorticoids: role of MKP-1.Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantationIn vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct.Engineered VEGF-releasing PEG-MAL hydrogel for pancreatic islet vascularization.Isolation, characterization and potential role in beta cell-endothelium cross-talk of extracellular vesicles released from human pancreatic isletsIntraportal islet oxygenation.Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cellsUnstable Expression of Commonly Used Reference Genes in Rat Pancreatic Islets Early after Isolation Affects Results of Gene Expression StudiesExperimental studies on islets isolation, purification and function in rats.PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.Subcutaneous transplantation of embryonic pancreas for correction of type 1 diabetes.γ-Aminobutyric acid regulates both the survival and replication of human β-cells.Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.Assessment of beta cell viability.Stem cell culture engineering - process scale up and beyond.PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine.Expression of Transforming Growth Factor-β by Human Islets: Impact on Islet Viability and Function.Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine modelsMesenchymal Stromal Cells as a Therapeutic Strategy to Support Islet Transplantation in Type 1 Diabetes Mellitus.Development and Validation of Noninvasive Magnetic Resonance Relaxometry for the In Vivo Assessment of Tissue-Engineered Graft Oxygenation.Intra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation.Bio-synthetic materials for immunomodulation of islet transplants.Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.Dual perfluorocarbon method to noninvasively monitor dissolved oxygen concentration in tissue engineered constructs in vitro and in vivo.The effects of cell density and device arrangement on the behavior of macroencapsulated beta-cells.Mitigating Ischemic Injury of Stem Cell-Derived Insulin-Producing Cells after TransplantGlucose-regulated insulin production in the liver improves glycemic control in type 1 diabetic miceA Metabolomic Approach (1H HRMAS NMR Spectroscopy) Supported by Histology to Study Early Post-transplantation Responses in Islet-transplanted Livers.Repurposing Lesogaberan to Promote Human Islet Cell Survival and β-Cell Replication.Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies.Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft.Endothelial microparticles released by activated protein C protect beta cells through EPCR/PAR1 and annexin A1/FPR2 pathways in islets.
P2860
Q26752205-D5A11F5D-338D-4E22-B2EE-324931778A10Q27010290-E4E491D4-D61B-4B85-96F4-CD16E3F53C05Q31028641-32F1E887-EC27-4F5D-8977-F271273F68F4Q31143578-E963DD29-7F48-416A-A1F1-E4524DE35165Q33647542-0D88CA13-D2A6-4A93-94C7-EA95EE11ED9FQ33758370-06D1D407-3D84-4266-AE8F-D7F4F8A838FCQ33869805-EA1B2B98-FD82-4643-9317-53E4DDAE7BFFQ34217750-C54B4D53-8488-449F-BB0C-54E474411099Q34442623-DE651ED0-8D5B-4C2F-9EEF-C1C433350AB5Q34527135-76A3F975-443B-468C-8DA8-0D97EE64351CQ35182799-C1F24354-B271-4DB6-9F1C-765CA991C83FQ35197394-9067DE1C-4D73-4617-8011-6D527F0B8FA8Q35207532-9B43E182-DFCB-4507-BC8D-C359059438D5Q35682824-E1F75D74-69A8-4154-962B-F3467C8675FBQ35857021-1599F2BE-242D-4C0C-9BBE-58C29598FD73Q35976723-18F821C3-77CD-430A-B3DE-1790D9D4F2CEQ36492913-6F20A96C-8221-4D22-BC59-8833C5466CF5Q36801593-46FD5E79-855C-4467-9F28-D6694FBBCB18Q37102844-A756CCC5-BC83-4D9C-B70B-56C9AB641018Q37251179-10FDAC93-F77C-456F-9E6C-7B92A74173EFQ37404257-F0ECC93E-515D-4D9D-A1ED-C6989052D888Q37826154-6028C30B-E316-4A19-900B-53A3B21E8580Q37896560-3FFA0FE5-754E-4BE2-A54F-E43364294FD6Q38123690-9D4CBCBE-AD44-4952-B816-786D687CDC8FQ38604128-4A6A7625-384A-4107-A1D3-EA525C59F998Q38739608-98723E67-7BA3-4000-9A93-5D0351330CA8Q38782963-0191299B-0A24-4F42-9523-C16B7703D737Q39272722-1B9C43E6-85C9-4853-B2FB-2207F863394FQ39308780-941EA236-C25E-4D78-97D2-600E958CBDBFQ39323041-7CC79FD6-01B3-460C-A112-BE59270CA4E5Q39394616-AF2923E9-9838-4B57-AAA5-0C61250E4F9BQ39537325-CB4935CA-EAD2-4792-808C-2A1C13773EC7Q40034090-31FD232D-1D44-42E2-8511-98460D16BF52Q41063199-83F196A8-BD2C-493C-A78E-7EC25DA76CE5Q41429641-1F7F3D3A-D37D-4DA4-8ABA-96E178641568Q41496936-5445BEA0-4691-4985-BAD3-EA20D7DF6A4FQ42006489-BCB03B36-57EF-4591-B2BA-6B9266D6EA56Q42573643-CA074CED-C567-4C40-9F15-25A30AE8733DQ42594941-349AD1E3-0BDC-4076-86DA-85AF3242F468Q43707258-56E1AEF5-58ED-4048-84E4-FBA1DD296DCA
P2860
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@ast
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@en
type
label
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@ast
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@en
prefLabel
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@ast
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@en
P2860
P1433
P1476
Factors Influencing the Loss of β-Cell Mass in Islet Transplantation.
@en
P2093
A M James Shapiro
Juliet A Emamaullee
P2860
P356
10.3727/000000007783464461
P577
2007-01-01T00:00:00Z